drugset / Trial / NCT06141447

Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation

NCT06141447 ↗

Phase 2 Recruiting 150 enrolled University of Colorado, Denver
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.

Timeline

Start
2024-05-02
Primary completion
2026-11-02
Completion
2026-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 40 iu Intravenous

Indications